Viewing Study NCT05543928


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2025-12-26 @ 10:36 AM
Study NCT ID: NCT05543928
Status: TERMINATED
Last Update Posted: 2025-07-25
First Post: 2022-09-13
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Sponsor: OPKO Health, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-01-31
Start Date Type: ACTUAL
Primary Completion Date: 2024-06-19
Primary Completion Date Type: ACTUAL
Completion Date: 2024-06-19
Completion Date Type: ACTUAL
First Submit Date: 2022-09-13
First Submit QC Date: None
Study First Post Date: 2022-09-16
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-07-08
Results First Submit QC Date: None
Results First Post Date: 2025-07-25
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-08
Last Update Post Date: 2025-07-25
Last Update Post Date Type: ACTUAL